LENZ Therapeutics News

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Sep 12 04:12

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 15 04:10

LENZ Therapeutics | 8-K: Current report

Aug 12 20:10

LENZ Therapeutics | 8-K: Current report

Jul 15 20:24

LENZ Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 21 20:35

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 9 04:10

LENZ Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 10 02:30

LENZ Therapeutics | 8-K: Current report

Apr 3 19:37

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 30 04:48

Therapeutics | 8-K: Current report

Mar 23 02:11

Graphite Bio | 8-K: Current report

Mar 20 04:37

Graphite Bio | 8-K: Current report

Mar 15 04:41

Graphite Bio | 8-K: Current report

Mar 9 06:17

Graphite Bio | 8-K: Current report

Mar 5 19:12

Graphite Bio | 8-K: Current report

Dec 26, 2023 13:00

Graphite Bio | 8-K: Current report

Nov 15, 2023 21:06

Graphite Bio | 8-K: Current report

Oct 31, 2023 04:08

Graphite Bio | 8-K/A: Current report (Amendment)

Sep 14, 2023 04:06

Graphite Bio | 8-K: Current report

Aug 24, 2023 04:06

Graphite Bio | 8-K: Current report

Aug 3, 2023 04:07